259 related articles for article (PubMed ID: 18799708)
21. Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
Worlock A; Blair D; Hunsicker M; Le-Nguyen T; Motta C; Nguyen C; Papachristou E; Pham J; Williams A; Vi M; Vinluan B; Hatzakis A
Virol J; 2017 Apr; 14(1):66. PubMed ID: 28372576
[TBL] [Abstract][Full Text] [Related]
22. Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms.
Vermehren J; Stelzl E; Maasoumy B; Michel-Treil V; Berkowski C; Marins EG; Paxinos EE; Marino E; Wedemeyer H; Sarrazin C; Kessler HH
J Clin Microbiol; 2017 Apr; 55(4):1131-1139. PubMed ID: 28122870
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum.
Germer JJ; Heimgartner PJ; Ilstrup DM; Harmsen WS; Jenkins GD; Patel R
J Clin Microbiol; 2002 Feb; 40(2):495-500. PubMed ID: 11825962
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
[TBL] [Abstract][Full Text] [Related]
25. Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors.
Wiesmann F; Naeth G; Sarrazin C; Berger A; Kaiser R; Ehret R; Knechten H; Braun P
Med Microbiol Immunol; 2015 Aug; 204(4):515-25. PubMed ID: 25398515
[TBL] [Abstract][Full Text] [Related]
26. Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
Taylor N; Haschke-Becher E; Greil R; Strasser M; Oberkofler H
Antivir Ther; 2014; 19(5):449-54. PubMed ID: 24430620
[TBL] [Abstract][Full Text] [Related]
27. Performance characteristics of a quantitative hepatitis C virus RNA assay using COBAS AmpliPrep total nucleic acid isolation and COBAS taqman hepatitis C virus analyte-specific reagent.
Forman MS; Valsamakis A
J Mol Diagn; 2008 Mar; 10(2):147-53. PubMed ID: 18276771
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.
Ronsin C; Pillet A; Bali C; Denoyel GA
J Clin Microbiol; 2006 Apr; 44(4):1390-9. PubMed ID: 16597867
[TBL] [Abstract][Full Text] [Related]
29. Abbott RealTime hepatitis C virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV assays for prediction of sustained virological response to pegylated interferon and ribavirin in chronic hepatitis C patients.
Matsuura K; Tanaka Y; Hasegawa I; Ohno T; Tokuda H; Kurbanov F; Sugauchi F; Nojiri S; Joh T; Mizokami M
J Clin Microbiol; 2009 Feb; 47(2):385-9. PubMed ID: 19091819
[TBL] [Abstract][Full Text] [Related]
30. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and monitoring of HCV infection using the cobas
Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.
Pyne MT; Brown KL; Hillyard DR
J Clin Microbiol; 2010 Aug; 48(8):2852-8. PubMed ID: 20573864
[TBL] [Abstract][Full Text] [Related]
33. Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.
Martinot-Peignoux M; Khiri H; Leclere L; Maylin S; Marcellin P; Halfon P
J Clin Virol; 2009 Nov; 46(3):216-21. PubMed ID: 19748822
[TBL] [Abstract][Full Text] [Related]
34. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
[TBL] [Abstract][Full Text] [Related]
35. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
Gelderblom HC; Menting S; Beld MG
Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
[TBL] [Abstract][Full Text] [Related]
36. Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir.
Fevery B; Susser S; Lenz O; Cloherty G; Perner D; Gilles L; De Locht P; Picchio G; De Meyer S; Sarrazin C
J Clin Virol; 2015 Nov; 72():133-40. PubMed ID: 26513763
[TBL] [Abstract][Full Text] [Related]
37. Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.
Gourlain K; Soulier A; Pellegrin B; Bouvier-Alias M; Hézode C; Darthuy F; Rémiré J; Pawlotsky JM;
J Clin Microbiol; 2005 Apr; 43(4):1669-73. PubMed ID: 15814982
[TBL] [Abstract][Full Text] [Related]
38. Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.
Pawlotsky JM; Martinot-Peignoux M; Poveda JD; Bastie A; Le Breton V; Darthuy F; Rémiré J; Erlinger S; Dhumeaux D; Marcellin P
J Virol Methods; 1999 May; 79(2):227-35. PubMed ID: 10381092
[TBL] [Abstract][Full Text] [Related]
39. Multilaboratory comparison of hepatitis C virus viral load assays.
Caliendo AM; Valsamakis A; Zhou Y; Yen-Lieberman B; Andersen J; Young S; Ferreira-Gonzalez A; Tsongalis GJ; Pyles R; Bremer JW; Lurain NS
J Clin Microbiol; 2006 May; 44(5):1726-32. PubMed ID: 16672399
[TBL] [Abstract][Full Text] [Related]
40. A comparative evaluation between real time Roche COBas TAQMAN 48 HCV and bDNA Bayer Versant HCV 3.0.
Giraldi C; Noto A; Tenuta R; Greco F; Perugini D; Spadafora M; Bianco AM; Savino O; Natale A
New Microbiol; 2006 Oct; 29(4):243-50. PubMed ID: 17201090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
